Although promising, that study was too small to draw any robust conclusions and the use of asymptomatic men as controls meant that it did little to address one of the present clinical challenges of distinguishing patients with prostate cancer from those with non-malignant urological problems that often result in a raised PSA level; in the earlier study only one of the controls have a raised PSA. Here, KLK3 is linked to prostate carcinoma.